{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T08:11:25Z","timestamp":1771920685413,"version":"3.50.1"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T00:00:00Z","timestamp":1768348800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["RO1HL16091102, RO1HL169253"],"award-info":[{"award-number":["RO1HL16091102, RO1HL169253"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>\n                      Cystic fibrosis (CF) is an autosomal recessive disorder, which manifests in many organ systems including the lungs. Chronic inflammation is a hallmark of CF lung disease leading to bronchiectasis and lung function decline. This is worsened by airway colonization and recurrent infections due to opportunistic pathogens such as\n                      <jats:italic>Pseudomonas aeruginosa<\/jats:italic>\n                      [PA], but the crosstalk between host-bronchial epithelium and immune system has been under characterized. Extracellular vesicles have been found to mediate intercellular crosstalk in different lung diseases and EVs have been shown to be increased in the bronchoalveolar fluid of CF patients. We hypothesize that EVs from PA-infected CF bronchial epithelial cells can modulate pro-inflammatory cytokines and neutrophil migration and activation in an autocrine and paracrine manner.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CF bronchial epithelial cells (CFBEs) and control bronchial epithelial cells (16HBEs) were infected with PA for 24 hours followed by EV isolation, which were used to treat uninfected CFBE and 16HBEs to assess expression and secretion of pro-inflammatory markers. In addition, the effects of EVs on neutrophil migration and activation were determined as well as the role of CFTR deficiency by using CFTR modulator therapy (Elexacaftor\/Tezacaftor\/Ivacaftor).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>EVs derived from PA infected CFBEs (EVpPAs) increased IL-6, IL-8, and TNF\u03b1 expression and neutrophil activation in CFBEs but not in 16HBEs. Interestingly, the effect of EVpPAs on inflammation was not attenuated by pre-treatment with ETI.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>EVs from the PA-infected CF bronchial epithelium seem to facilitate an autocrine and paracrine pro-inflammatory response that is not attenuated by ETI treatment, suggesting a novel contribution of EVs to the chronic inflammatory phenotype observed in the PA-infected CF lung.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1659951","type":"journal-article","created":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T06:33:47Z","timestamp":1768372427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Epithelial extracellular vesicles induce inflammation and neutrophil activation in the Pseudomonas aeruginosa infected cystic fibrosis bronchial epithelium"],"prefix":"10.3389","volume":"16","author":[{"given":"Meghan June","family":"Hirsch","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuen-You","family":"Tsai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luke I.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela N.","family":"Morales","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah J.","family":"McIntire-Ray","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick H.","family":"Howze IV","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarrod W.","family":"Barnes","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camilla","family":"Margaroli","sequence":"additional","affiliation":[{"name":"Department of Pathology, Division of Molecular and Cellular Pathology, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristopher","family":"Genschmer","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefanie","family":"Krick","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Heersink School of Medicine, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]},{"name":"Gregory Fleming James Cystic Fibrosis Research Center, University of Alabama at Birmingham","place":["Birmingham, AL, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.10.008","article-title":"Contemporary cystic fibrosis incidence rates in Canada and the United States","volume":"22","author":"Stephenson","year":"2023","journal-title":"J Cyst Fibros"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijns6010018","article-title":"Newborn screening for CF across the globe-where is it worthwhile","volume":"6","author":"Scotet","year":"2020","journal-title":"Int J Neonatal Screen"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J Cyst Fibros"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)00576-6","article-title":"Cystic fibrosis","volume":"388","author":"Elborn","year":"2016","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)12567-6","article-title":"Cystic fibrosis","volume":"361","author":"Ratjen","year":"2003","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201609-1954OC","article-title":"Restoring cystic fibrosis transmembrane conductance regulator function reduces airway bacteria and inflammation in people with cystic fibrosis and chronic lung infections","volume":"195","author":"Hisert","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"B7","volume-title":"Patient Registry Annual Data Report2024","author":"Foundation","year":"2023"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00138-18","article-title":"Cystic fibrosis and pseudomonas aeruginosa: the host-microbe interface","volume":"32","author":"Malhotra","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02416","article-title":"Pseudomonas aeruginosa in chronic lung infections: how to adapt within the host","volume":"9","author":"Faure","year":"2018","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22063128","article-title":"Pseudomonas aeruginosa: an audacious pathogen with an adaptable arsenal of virulence factors","volume":"22","author":"Jurado-Martin","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B11","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.jcf.2019.04.009","article-title":"Mucoid Pseudomonas aeruginosa and regional inflammation in the cystic fibrosis lung","volume":"18","author":"Malhotra","year":"2019","journal-title":"J Cyst Fibros"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e0288002","DOI":"10.1371\/journal.pone.0288002","article-title":"A novel in vitro model to study prolonged Pseudomonas aeruginosa infection in the cystic fibrosis bronchial epithelium","volume":"18","author":"Hirsch","year":"2023","journal-title":"PLoS One"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.5HI1117-454RR","article-title":"Frontline Science: Pathological conditioning of human neutrophils recruited to the airway milieu in cystic fibrosis","volume":"104","author":"Forrest","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xpro.2021.100892","article-title":"Mass production of human airway-like neutrophils via transmigration in an organotypic model of human airways","volume":"2","author":"Dobosh","year":"2021","journal-title":"STAR Protoc"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/imcb.12547","article-title":"Western Australian Epithelial Research P, Australian Respiratory Early Surveillance Team for CF. Pseudomonas aeruginosa modulates neutrophil granule exocytosis in an in vitro model of airway infection","volume":"100","author":"Laucirica","year":"2022","journal-title":"Immunol Cell Biol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00005-011-0113-6","article-title":"The cystic fibrosis neutrophil: a specialized yet potentially defective cell","volume":"59","author":"Hayes","year":"2011","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B17","doi-asserted-by":"publisher","first-page":"e0051924","DOI":"10.1128\/mbio.00519-24","article-title":"Persistence and evolution of Pseudomonas aeruginosa following initiation of highly effective modulator therapy in cystic fibrosis","volume":"15","author":"Armbruster","year":"2024","journal-title":"mBio"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1172\/JCI184171","article-title":"Elexacaftor\/tezacaftor\/ivacaftor\u2019s effects on cystic fibrosis infections are maintained, but not increased, after 3.5 years of treatment","volume":"134","author":"Morgan","year":"2024","journal-title":"J Clin Invest"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/antiox14030310","article-title":"How effectively can oxidative stress and inflammation be reversed when CFTR function is pharmacologically improved","volume":"14","author":"Villella","year":"2025","journal-title":"Antioxidants (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222242","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on systemic inflammation in cystic fibrosis","volume":"80","author":"Maher","year":"2025","journal-title":"Thorax"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1177\/17534666251314706","article-title":"Elexacaftor\/tezacaftor\/ivacaftor and inflammation in children and adolescents with cystic fibrosis: a retrospective dual-center cohort study","volume":"19","author":"Pepe","year":"2025","journal-title":"Ther Adv Respir Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2025.1566495","article-title":"Wound repair and immune function in the Pseudomonas infected CF lung: before and after highly effective modulator therapy","volume":"15","author":"Matthews","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-025-05331-x","article-title":"Elexacaftor\/tezacaftor\/ivacaftor (ETI) therapy modifies the expression of interferon beta and inflammatory genes in the airways of adult patients with cystic fibrosis: a pilot study","volume":"480","author":"Bitossi","year":"2025","journal-title":"Mol Cell Biochem"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1486784","article-title":"Proteomics profiling of inflammatory responses to elexacaftor\/tezacaftor\/ivacaftor in cystic fibrosis","volume":"16","author":"Ozuna","year":"2025","journal-title":"Front Immunol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1126\/science.aau6977","article-title":"The biology, function, and biomedical applications of exosomes","volume":"367","author":"Kalluri","year":"2020","journal-title":"Science"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112189","article-title":"Involvement of epithelia-derived exosomes in chronic respiratory diseases","volume":"143","author":"Yang","year":"2021","journal-title":"BioMed Pharmacother"},{"key":"B27","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.cell.2018.12.002","article-title":"Activated PMN exosomes: pathogenic entities causing matrix destruction and disease in the lung","volume":"176","author":"Genschmer","year":"2019","journal-title":"Cell"},{"key":"B28","first-page":"66","article-title":"Immunologic role of extracellular vesicles and exosomes in the pathogenesis of cystic fibrosis","volume":"17","author":"Asef","year":"2018","journal-title":"Tanaffos"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jprot.2018.07.001","article-title":"Comparative proteomics of respiratory exosomes in cystic fibrosis, primary ciliary dyskinesia and asthma","volume":"185","author":"Rollet-Cohen","year":"2018","journal-title":"J Proteomics"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2019-214027","article-title":"Increased extracellular vesicles mediate inflammatory signalling in cystic fibrosis","volume":"75","author":"Useckaite","year":"2020","journal-title":"Thorax"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2023.02.005","article-title":"Investigating serum extracellular vesicles in Cystic Fibrosis","volume":"22","author":"Trappe","year":"2023","journal-title":"J Cyst Fibros"},{"key":"B32","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1186\/s12964-024-01609-7","article-title":"Extracellular vesicles released by host epithelial cells during Pseudomonas aeruginosa infection function as homing beacons for neutrophils","volume":"22","author":"Ayilam Ramachandran","year":"2024","journal-title":"Cell Commun Signal"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41467-023-36932-z","article-title":"Multiplexed analysis of EV reveals specific biomarker composition with diagnostic impact","volume":"14","author":"Spitzberg","year":"2023","journal-title":"Nat Commun"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/medicina59091635","article-title":"Fibroblast growth factor 23 signaling does not increase inflammation from pseudomonas aeruginosa infection in the cystic fibrosis bronchial epithelium","volume":"59","author":"Hirsch","year":"2023","journal-title":"Med (Kaunas)"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.174888","article-title":"FGF receptors mediate cellular senescence in the cystic fibrosis airway epithelium","volume":"9","author":"Easter","year":"2024","journal-title":"JCI Insight"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M410618200","article-title":"Chronic airway infection\/inflammation induces a Ca2+i-dependent hyperinflammatory response in human cystic fibrosis airway epithelia","volume":"280","author":"Ribeiro","year":"2005","journal-title":"J Biol Chem"},{"key":"B37","doi-asserted-by":"publisher","first-page":"14388","DOI":"10.1038\/s41598-017-14811-0","article-title":"Klotho inhibits interleukin-8 secretion from cystic fibrosis airway epithelia","volume":"7","author":"Krick","year":"2017","journal-title":"Sci Rep"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1002\/ppul.27355","article-title":"Infection and Inflammation in the Cystic fibrosis (CF) airway","author":"Cohen-Cymberknoh","year":"2025","journal-title":"Pediatr Pulmonol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.173.9.5659","article-title":"Pseudomonas aeruginosa flagellin and alginate elicit very distinct gene expression patterns in airway epithelial cells: implications for cystic fibrosis disease","volume":"173","author":"Cobb","year":"2004","journal-title":"J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1172\/JCI2865","article-title":"Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells","volume":"101","author":"DiMango","year":"1998","journal-title":"J Clin Invest"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712386105","article-title":"Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways","volume":"105","author":"Tirouvanziam","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1101\/2023.01.22.23284619","article-title":"Aberrant immune programming in neutrophils in cystic fibrosis","volume":"115","author":"Hu","year":"2023","journal-title":"medRxiv"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21030851","article-title":"Neutrophil adaptations upon recruitment to the lung: new concepts and implications for homeostasis and disease","volume":"21","author":"Giacalone","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100239","article-title":"Transcriptional firing represses bactericidal activity in cystic fibrosis airway neutrophils","volume":"2","author":"Margaroli","year":"2021","journal-title":"Cell Rep Med"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/apm.13444","article-title":"Outer membrane vesicles from X-ray-irradiated Pseudomonas aeruginosa alleviate lung injury caused by P","volume":"132","author":"Bi","year":"2024","journal-title":"aeruginosa infection-mediated sepsis. APMIS"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00316.2018","article-title":"Cyclodextrins reduce the ability of Pseudomonas aeruginosa outer-membrane vesicles to reduce CFTR Cl(-) secretion","volume":"316","author":"Barnaby","year":"2019","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2105370118","article-title":"Let-7b-5p in vesicles secreted by human airway cells reduces biofilm formation and increases antibiotic sensitivity of P","volume":"118","author":"Koeppen","year":"2021","journal-title":"aeruginosa. Proc Natl Acad Sci U S A"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00253.2023","article-title":"Extracellular vesicles secreted by primary human bronchial epithelial cells reduce Pseudomonas aeruginosa burden and inflammation in cystic fibrosis mouse lung","volume":"326","author":"Sarkar","year":"2024","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.02316","article-title":"CD9 tetraspanin: A new pathway for the regulation of inflammation","volume":"9","author":"Brosseau","year":"2018","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2022-219943","article-title":"Effect of elexacaftor\/tezacaftor\/ivacaftor on airway and systemic inflammation in cystic fibrosis","volume":"78","author":"Casey","year":"2023","journal-title":"Thorax"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1180282","article-title":"Multimodal analysis of granulocytes, monocytes, and platelets in patients with cystic fibrosis before and after Elexacaftor-Tezacaftor-Ivacaftor treatment","volume":"14","author":"Schmidt","year":"2023","journal-title":"Front Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.619442","article-title":"CFTR Correctors and Antioxidants Partially Normalize Lipid Imbalance but not Abnormal Basal Inflammatory Cytokine Profile in CF Bronchial Epithelial Cells","volume":"12","author":"Veltman","year":"2021","journal-title":"Front Physiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00970-2024","article-title":"Deleterious effect of Pseudomonas aeruginosa on F508del-CFTR rescued by elexacaftor\/tezacaftor\/ivacaftor is clinical strain-dependent in patient-derived nasal cells","volume":"11","author":"Allegretta","year":"2025","journal-title":"ERJ Open Res"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.628722","article-title":"Airway epithelial inflammation in vitro augments the rescue of mutant CFTR by current CFTR modulator therapies","volume":"12","author":"Gentzsch","year":"2021","journal-title":"Front Pharmacol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22052530","article-title":"Functional and transcriptional adaptations of blood monocytes recruited to the cystic fibrosis airway microenvironment in vitro","volume":"22","author":"Ford","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"crossref","DOI":"10.1002\/9783527634286.ch12","article-title":"An integrative approach for immune monitoring of human health and disease by advanced flow cytometry methods","volume-title":"Advanced Optical Flow Cytometry","author":"Tirouvanziam","year":"2011"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1659951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T05:39:37Z","timestamp":1771911577000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1659951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,14]]},"references-count":56,"alternative-id":["10.3389\/fimmu.2025.1659951"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1659951","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,14]]},"article-number":"1659951"}}